Martini Gregory S., CFO of Ironwood Pharmaceuticals ($IRWD), made three open market sales of company shares over the past year, totaling about $83,000. His most recent sale occurred on February 24, 2026. These sales rank 9,820th among nearly 12,000 insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Martini Gregory S. | Chief Financial Officer | A | Class A Common Stock | 136612 | $0.00 | 297,213.0000 | 162,983,000 | 85.06% | 0.08% |
| Feb. 23, 2026 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 10487 | $3.81 | 172,058.0000 | 162,983,000 | 5.74% | 0.01% |
| Feb. 24, 2026 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 11457 | $3.66 | 160,601.0000 | 162,983,000 | 6.66% | 0.01% |
| Aug. 11, 2025 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 1265 | $0.84 | 182,545.0000 | 176,837,000 | 0.69% | 0.00% |
| Feb. 10, 2025 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 12052 | $1.76 | 183,810.0000 | 160,084,000 | 6.15% | 0.01% |
| Jan. 27, 2025 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Martini Gregory S. | Chief Financial Officer | A | Class A Common Stock | 111111 | $0.00 | 195,862.0000 | 160,084,000 | 131.10% | 0.07% |